Search Results

Your search for Syed Ali Abutalib, MD, and Miguel-Angel Perales, MD,Syed Ali Abutalib, MD, and Miguel-Angel Perales, MD matches 2 pages

Showing 1 - 2

By Syed Ali Abutalib, MD, and Miguel-Angel Perales, MD / March 10, 2022 / 2021 ASH Annual Meeting & Exposition

CAR T-Cell Therapy as Second-Line Treatment in Large B-Cell Lymphomas

“The mind is not a vessel to be filled but a fire to be kindled.” —Plutarch About 30% to 40% of patients with newly diagnosed diffuse large B-cell lymphoma (DLBCL) experience relapse, and 10% are refractory to the...

hematologic malignancies

By Alice Goodman / March 25, 2020

HAPLO2019: Advances in Haploidentical Transplantation and Other Novel Cellular Therapies

Now in its seventh year, the Haploidentical Transplant Symposium (HAPLO) continues to explore advances in haploidentical and other novel cellular therapies. The most recent of these meetings—HAPLO2019—met in Orlando, Florida, 2 days before the start of the 2019 American Society of Hematology (ASH)...

Nov

Today In Oncology

Search Results

Your search for Syed Ali Abutalib, MD, and Miguel-Angel Perales, MD,Syed Ali Abutalib, MD, and Miguel-Angel Perales, MD matches 2 pages

CAR T-Cell Therapy as Second-Line Treatment in Large B-Cell Lymphomas

HAPLO2019: Advances in Haploidentical Transplantation and Other Novel Cellular Therapies

What Is the Impact of a Colon or Colorectal Cancer Diagnosis on Younger Adults?

International Cancer Organizations Present Collaborative Work During Oncology Event in China

Is There a Role for Neoadjuvant Chemotherapy in HR-Positive, HER2-Negative Early Breast Cancer?

Suicide-Related Mortality in Male AYA Cancer Survivors

Four-Year Asian Subpopulation Data From the CheckMate 816 Trial of Neoadjuvant Nivolumab Plus Chemotherapy in Resectable NSCLC